About
Lyterian Therapeutics develops medicines that co-opt physiologically relevant protein homeostatic mechanisms to regulate genetically-validated targets for disease treatment.
Explore Lyterian's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.